Renovo Group PLC (RNVO.L)
-LSE 19.30 
0.08(0.41%) May 23
| Prev Close: | 18.88 |
|---|
| Open: | 18.54 |
|---|
| Bid: | 18.00 |
|---|
| Ask: | 19.25 |
|---|
| 1y Target Est: | 22.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 18.54 - 19.00 |
|---|
| 52wk Range: | 16.50 - 19.75 |
|---|
| Volume: | 26,492 |
|---|
| Avg Vol (3m): | 23,114 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Headlines
- No Headlines available for RNVO.L at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | -0.50 |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Renovo Group plc, a biopharmaceutical product company, engages in the discovery and development of drugs to reduce scarring, improve wound healing, and enhance tissue regeneration in the United Kingdom.
View More